Skip to main content
AMCP Nexus 2024 Main banner

Legislative and Regulatory Trends

(L6) CY 2025 Part D Redesign: A Medicare Odyssey

Wednesday, October 16, 2024
4:15 PM - 5:30 PM PT
Location: 123
CPE
ACPE UAN:0233-0000-24-060-L03-P | Contact Hours: 1.25 (Law) | Activity Type: Knowledge-based
The CY 2025 Medicare Part D Redesign will introduce changes that will impact how people view Medicare. The implications of the IRA and its provisions continue to impact every stakeholder from beneficiaries and health plans to PBMs and pharmaceutical manufacturers.

This session will focus on the successes and challenges that stakeholders are experiencing as they prepare for the CY 2025 Medicare Part D redesign as well as the Medicare Prescription Payment Plan. Additionally, the session will discuss considerations that should be addressed prior to going live on January 1, 2025.

Learning Objectives:

At the completion of this activity, participants should be able to:
  1. Describe the early successes and challenges managed care stakeholders are experiencing following the implementation of certain provisions of the Inflation Reduction Act (i.e., drug price negotiation, Part D redesign).
  2. Explain the formulary/benefit design actions that are being taken at the PBM and health plan levels based on the Inflation Reduction Act, including how the government drug price negotiations will impact the rest of the marketplace.
  3. Identify the effect that changes to the Part D benefit in 2025 may have on patient choices and the consumerism of health care.
  4. Summarize the steps that plans should take between now and the end of the year to be prepared for January 1, 2025.